NCT04779008

Brief Summary

Remote Ischemic preconditioning (RIPC) has been reported to improve myocardial microcirculation, promote collateral circulation recruitment, and improve myocardial perfusion in patients.Two large randomized controlled trials demonstrated a perioperative cardioprotective effect of RIPC (reduced troponin levels), but did not find that a single preoperative RIPC improved long-term outcomes of coronary artery bypass grafting(CABG).The effect of a single RIPC before CABG may be too short. This study aims to investigate whether long-term RIPC improved myocardial perfusion in patients 3 months and 6 months after CABG surgery , and to detect changes in blood vascular endothelial growth factor, Nitrc Oxide, adenosine,and Endothelin-1, and to observe MACCE event rates at 12 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Mar 2021Dec 2026

First Submitted

Initial submission to the registry

February 4, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

March 10, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

4.7 years

First QC Date

February 4, 2021

Last Update Submit

September 12, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change of MBF by SPECT

    Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial blood flow(MBF)

    3 months

  • Change of MPR by SPECT

    Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial perfusion reserve(MPR)

    3 months

  • Change of MBF by CE

    Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial blood flow(MBF)

    3 months

  • Change of MPR by CE

    Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial perfusion reserve(MPR)

    3 months

Secondary Outcomes (15)

  • MBF by SPECT

    1 weeks

  • MPR by SPECT

    1 weeks

  • MBF by CE

    1 weeks

  • MPR by CE

    1 weeks

  • Rate of major adverse cardiovascular and cerebrovascular events

    12 months

  • +10 more secondary outcomes

Study Arms (3)

Experimental Group 1

EXPERIMENTAL

Routine treatment + interventions:The patient underwent one RIPC (Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff air vehicle to 200 mmHg) before surgery, then normal surgery, and RIPC was performed on the second day and Once RIPC/day after CABG for one year.

Other: remote ischemic preconditioning (RIPC)

Experimental Group 2

EXPERIMENTAL

Routine treatment + interventions:Patients underwent a RIPC before surgery, and then normal medical procedures were performed with no additional intervention.

Other: remote ischemic preconditioning (RIPC)

Control group

NO INTERVENTION

routine treatment, no RIPC

Interventions

Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff inflated to 200 mmHg.

Experimental Group 1Experimental Group 2

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Three coronary artery lesions, CABG surgery was planned

You may not qualify if:

  • The patients could not tolerate ripc;
  • peripheral vascular disease affecting upper limbs
  • Acute myocardial infarction complicated with cardiogenic shock,in recent 30 days,
  • Emergency cases
  • Severe structural heart disease and severe arrhythmia ;
  • The uncontrolled systolic blood pressure and diastolic blood pressure of severe hypertension were 180 mmHg and 120 mmHg respectively;
  • Severe liver, renal and pulmonary disease
  • Mental disorder can't cooperate;
  • Inability to give informed consent;
  • Patients on glibenclamide or nicorandil, as these medications may interfere with RIC
  • pregnant;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai central China cardiovascular Hospital

Zhengzhou, Henan, China

RECRUITING

Related Publications (4)

  • Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008 Aug 1;79(3):377-86. doi: 10.1093/cvr/cvn114. Epub 2008 May 2.

    PMID: 18456674BACKGROUND
  • Lau JK, Roy P, Javadzadegan A, Moshfegh A, Fearon WF, Ng M, Lowe H, Brieger D, Kritharides L, Yong AS. Remote Ischemic Preconditioning Acutely Improves Coronary Microcirculatory Function. J Am Heart Assoc. 2018 Oct 2;7(19):e009058. doi: 10.1161/JAHA.118.009058.

    PMID: 30371329BACKGROUND
  • Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K; RIPHeart Study Collaborators. A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. N Engl J Med. 2015 Oct 8;373(15):1397-407. doi: 10.1056/NEJMoa1413579. Epub 2015 Oct 5.

    PMID: 26436208BACKGROUND
  • Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM; ERICCA Trial Investigators. Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med. 2015 Oct 8;373(15):1408-17. doi: 10.1056/NEJMoa1413534. Epub 2015 Oct 5.

    PMID: 26436207BACKGROUND

MeSH Terms

Conditions

Coronary Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Muwei Li, Ph.D

    Fuwai central China cardiovascular hospotial

    PRINCIPAL INVESTIGATOR
  • Zhaoyun Cheng, Ph.D

    Fuwai central China cardiovascular hospotial

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental Group 1:The patient underwent one RIPC (Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff air vehicle to 200 mmHg) 4 hours before surgery, then normal surgery, and RIPC was performed on the second day after surgery and every day after surgery, which lasted for 1 year. Experiment Group 2: Patients underwent once RIPC 4 hours before surgery, and then normal medical procedures were performed with no additional intervention. Control group: Patients did not receive any additional intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2021

First Posted

March 3, 2021

Study Start

March 10, 2021

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

One year after the end of the trial, other outside investigators could access the original data on reasonable requests

Locations